FY 2001 user fees
This article was originally published in The Tan Sheet
Executive Summary
Drug applications requiring clinical data will cost $309,647, an 8.4% increase from $285,740 in FY 2000. Applications not requiring clinical data and applications for supplements requiring clinical data will cost half that amount: $154,823, up from $142,870 in FY 2000. FDA projects receipt of 163.6 fee-paying full application-equivalent submissions in FY 2001, 10.1 more than FY 2000's 153.5 estimated receipts. The agency incorporates an FY 2000 inflation adjustment of 3.81% into its FY 2001 user fee rate
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning